Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Breast cancer and hormonal supplements in postmenopausal women.

Literature DB >> 7549673

Breast cancer and hormonal supplements in postmenopausal women.

K McPherson.

Abstract

Entities: Disease Species

Mesh：

Year: 1995 PMID： 7549673 PMCID： PMC2550711 DOI： 10.1136/bmj.311.7007.699

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

10 in total

Review 1. Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors: D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal: Ann Intern Med Date: 1992-12-15 Impact factor: 25.391

2. Complications of hormone replacement therapy in post-menopausal women.

Authors: J Studd
Journal: J R Soc Med Date: 1992-07 Impact factor: 5.344

3. The risk of breast cancer after estrogen and estrogen-progestin replacement.

Authors: L Bergkvist; H O Adami; I Persson; R Hoover; C Schairer
Journal: N Engl J Med Date: 1989-08-03 Impact factor: 91.245

Review 4. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.

Authors: M C Pike; D V Spicer; L Dahmoush; M F Press
Journal: Epidemiol Rev Date: 1993 Impact factor: 6.222

5. Measuring the impact of menopausal symptoms on quality of life.

Authors: E Daly; A Gray; D Barlow; K McPherson; M Roche; M Vessey
Journal: BMJ Date: 1993-10-02

6. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies.

Authors: G A Colditz; K M Egan; M J Stampfer
Journal: Am J Obstet Gynecol Date: 1993-05 Impact factor: 8.661

7. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

Authors: G A Colditz; S E Hankinson; D J Hunter; W C Willett; J E Manson; M J Stampfer; C Hennekens; B Rosner; F E Speizer
Journal: N Engl J Med Date: 1995-06-15 Impact factor: 91.245

8. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group.

Authors:
Journal: Ann Epidemiol Date: 1994-01 Impact factor: 3.797

9. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.

Authors: R D Gambrell; R C Maier; B I Sanders
Journal: Obstet Gynecol Date: 1983-10 Impact factor: 7.661

10. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.

Authors: M Packer; M Gheorghiade; J B Young; P J Costantini; K F Adams; R J Cody; L K Smith; L Van Voorhees; L A Gourley; M K Jolly
Journal: N Engl J Med Date: 1993-07-01 Impact factor: 91.245

10 in total

9 in total

Breast cancer and hormonal supplements in postmenopausal women.

Review 1. Hormone therapy to prevent disease and prolong life in postmenopausal women.

2. Complications of hormone replacement therapy in post-menopausal women.

3. The risk of breast cancer after estrogen and estrogen-progestin replacement.

Review 4. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.

5. Measuring the impact of menopausal symptoms on quality of life.

6. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies.

7. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

8. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group.

9. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.

10. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.

1. Why do women doctors in the UK take hormone replacement therapy?

2. Women need to be fully informed about risks of hormone replacement therapy.

3. Use of hormone replacement therapy. Authors gave distorted view through selective citation.

4. Oral contraceptives and breast cancer.

5. HRT and heart disease.

6. Breast cancer and hormonal supplements in postmenopausal women. Article increased uncertainty.

7. Breast cancer and hormonal supplements in postmenopausal women. Benefits probably outweight risks.

Review 8. Prevention and management of osteoporosis. Current trends and future prospects.

9. Breast cancer and hormonal supplements in postmenopausal women. Increase in risk of breast cancer is small.